.jpg)
.jpg)
Princess Margaret Cancer Center, UHN, University of Toronto
Dr. Antonio Finelli is the Divisional Head of Urology, within the Department of Surgical Oncology at Princess Margaret Cancer Centre. He is the current Anna-Liisa Farquharson Chair in Kidney Cancer Research, a urologic oncologist, clinician investigator and a Professor at the University of Toronto. Dr. Finelli previously served as the Ontario Genitourinary Cancer Lead for CCO and the Head of Genitourinary Cancer Site Group at Princess Margaret Cancer Centre.
Tony Finelli attended the University of Toronto where he earned his Doctor of Medicine. Later he completed his postgraduate training in urology and a Master’s of Science degree through the Surgical Scientist Program. Dr. Finelli received advanced training in minimally invasive urologic oncology at the Cleveland Clinic Foundation and undertook another Master’s degree in the department of Health, Policy, Management and Evaluation. He was also the recipient of the Bernard Langer Surgeon Scientist Award that acknowledges an outstanding graduate of the Surgeon Scientist Program in the Department, who shows the greatest promise for a career in academic surgery. In 2017 Dr. Finelli received the Innovation in Education Award, that is presented to an exceptional and innovative patient care provider that stands out for excellence, innovative spirit and commitment to learners.
Dr. Finelli’s clinical practice focuses on the management of urologic malignancies and in particular prostate and kidney cancer. His expertise and research interests span from clinical trials to retrospective research including natural history, active surveillance, treatment and quality of health care delivery.
He has received peer-reviewed funding for his research and has produced more than 315 manuscripts. He has also received multiple major scientist awards and grants from agencies such as CIHR, PCC and CCSRI both as the principal investigator ad co-investigator. Dr. Finelli is recognized nationally and internationally for his contributions to minimally invasive and robotic urologic surgery.
Disclosure information not submitted.
Monday, May 16, 2022
7:30 AM – 9:30 AM